Overview of the process to generate and validate a RNA-seq gene signature to determine optimal treatment. CoMMpass, Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile; OS, overall survival; PAD, bortezomib, adriamycin, and dexamethasone.

Overview of the process to generate and validate a RNA-seq gene signature to determine optimal treatment. CoMMpass, Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile; OS, overall survival; PAD, bortezomib, adriamycin, and dexamethasone.

Close Modal

or Create an Account

Close Modal
Close Modal